Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:41:12 EDT Tue 15 Jul 2025
Enter Symbol
or Name
USA
CA



Q:CELZ - CREATIVE MEDICAL TECH HOLDING INC - https://www.creativemedicaltechnology.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CELZ - Q0.12.41·2.800.12.51-0.13-4.9127.63034592.65  2.71  2.506.90  1.7416:25:47Jul 1115 min RT 2¢

Recent Trades - Last 10 of 459
Time ETExPriceChangeVolume
16:25:47Q2.36-0.2810
16:23:54Q2.43-0.218
16:23:54Q2.44-0.2057
16:23:33Q2.48-0.1612
16:23:33Q2.45-0.198
16:20:18Q2.4106-0.22943,767
16:20:18Q2.41-0.23500
16:00:01Q2.51-0.1333
16:00:01Q2.51-0.131
16:00:01Q2.51-0.1369

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-11 08:01U:CELZNews ReleaseCreative Medical Technology Holdings Receives Notice of Allowance for ImmCelz(TM) for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling
2025-03-20 07:50U:CELZNews ReleaseCreative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
2025-03-06 08:10U:CELZNews ReleaseCreative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
2025-02-20 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem(TM) Program's Success and Growth Potential
2025-02-14 07:01U:CELZNews ReleaseCreative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine(TM) Procedure using AlloStem(TM)
2025-02-11 09:25U:CELZNews ReleaseCreative Medical Technology Reports Positive One-Year Results for AlloStem(TM) Type 2 Diabetes Program
2025-02-05 08:25U:CELZNews ReleaseCreative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
2025-01-30 09:25U:CELZNews ReleaseCreative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
2024-11-13 09:00U:CELZNews ReleaseCreative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
2024-10-23 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2024-07-24 09:01U:CELZNews ReleaseCreative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program